Human platelet-specific antigen frequencies in Indonesian population.
Autor: | Asmarinah; Department of Medical Biology, Faculty of Medicine, Universitas Indonesia. asmarinah.si@gmx.de, Dharma R, Ritchie NK, Rahayu S, Putricahya E, Santoso S |
---|---|
Jazyk: | angličtina |
Zdroj: | Transfusion medicine (Oxford, England) [Transfus Med] 2013 Aug; Vol. 23 (4), pp. 250-3. Date of Electronic Publication: 2013 Apr 25. |
DOI: | 10.1111/tme.12039 |
Abstrakt: | Background: Alloantibodies against human platelet antigens (HPAs) are responsible for the development of alloimmune thrombocytopenia including platelet transfusion refractoriness (PTR) and neonatal alloimmune thrombocytopenia (NAIT). Therefore, transfusion of HPA-compatible platelets is of importance for the management of these diseases. Aim: Determination of the allele frequency of the major HPA systems for Indonesian blood donors and the development of the first HPA-typed donor registry in Indonesia. Methods: DNA derived from 500 Indonesian healthy blood donors was genotyped for HPA-1 to HPA-6 and HPA-15 alleles by the use of polymerase chain reaction sequence-specific primer method. Results: The gene frequencies of the rare allelic variants HPA-1b, -2b, -3b, -4b, -5b, -6b and -15b were 0·023, 0·060, 0·493, 0·052, 0·032, 0·044 and 0·049, respectively. However, donors homozygous for the HPA-1b, -2b and -6b were not found in this cohort, indicating that the risks of alloimmunisation caused by incompatibility of these three HPA systems are extremely low. In contrast, alloimmunisation against HPA-3, -4, -5 and -15 systems is anticipated. Conclusion: The development of an HPA-genotyped registry for donors homozygous for HPA-1b, -2b and -6b is desired for the optimum management of PTR patients and children with NAIT. (© 2013 The Authors. Transfusion Medicine © 2013 British Blood Transfusion Society.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |